Methylprednisolone Acetate I · #20 of 35 active shortages by FDA posting duration
Brand: METHYLPREDNISOLONE ACETATE
FDA lists Methylprednisolone Acetate I as Active Shortage (Sagent Pharmaceuticals).
Availability on file: Available
Methylprednisolone Acetate Injection: Active Shortage
Available 23 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Methylprednisolone Acetate Injection
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection
- Presentation
- Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05)
- Package NDC
- 25021-821-05
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 15, 2021
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Rheumatology
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
methylprednisolone
Side effects, interactions, warnings & more
Nearby, Other Methylprednisolone Shortage Records
Methylprednisolone Acetate Injection
Eugia US LLC
Injection
Methylprednisolone Acetate Injection
Eugia US LLC
Injection
Methylprednisolone Acetate Injection
Par Health, USA LLC
Injection
Methylprednisolone Acetate Injection
Sagent Pharmaceuticals
Injection
Methylprednisolone Acetate Injection
Sagent Pharmaceuticals
Injection
Methylprednisolone Acetate Injection
Pfizer Inc.
Injection